SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Irène Joliot-Curie — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientIrène Joliot-Curie
Date of birth1897-09-12
IdentifiersMRN HR-RB003-SYN-TD; SSN (made up) 000-03-8841
Document date1955-09-16
AuthorSolène Marchand-Ellis, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-day review, seen the same morning by hematology for a bone marrow biopsy. [S]

History of Present Illness

Mrs. Joliot-Curie returns two days after her first visit and was seen this morning by Dr. Engquist-Mensah of hematology/oncology, who performed a bone marrow aspiration and biopsy. She feels more tired than two days ago and is breathless on one flight of stairs. Her gums still ooze when she brushes, and two new bruises have appeared on her thighs. She has had no fever, chills, nosebleeds, blood in the urine or stool, headache, or confusion. She has avoided aspirin as advised. She has written down her history of radiation work and the laboratory accident, and has begun asking her employer's radiation safety office for her dose records. [S]

ElementDetail
SymptomsMore tired; breathless on one flight; gum oozing; new bruises; no fever
Weight53.8 kg
Testing todayBone marrow aspiration and biopsy with flow cytometry, cytogenetics and molecular panel; blood count; INR and fibrinogen; hepatitis B, hepatitis C and HIV tests; HLA typing; chest X-ray

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; no fever, chills or night sweats
RespiratoryPositiveBreathless on one flight of stairs; no cough
Ears, nose, mouth, and throatPositiveGum oozing; no nosebleeds
IntegumentaryPositiveNew bruises on both thighs
NeurologicalNegativeNo headache, visual change or confusion

5 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1955-09-16Body height163cmS
1955-09-16Body weight53.8kgS
1955-09-16Body mass index (BMI) [Ratio]20.2kg/m2S
1955-09-16Systolic blood pressure114mm[Hg]S
1955-09-16Diastolic blood pressure68mm[Hg]S
1955-09-16Heart rate100/minS
1955-09-16Respiratory rate18/minS
1955-09-16Body temperature37.3CelS
1955-09-16Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1955-09-16Leukocytes [#/volume] in Blood by Automated count1.910*3/uL4-11 10*3/uLLowS
1955-09-16Neutrophils [#/volume] in Blood by Automated count0.510*3/uL1.5-7.5 10*3/uLLowS
1955-09-16Hemoglobin [Mass/volume] in Blood7.1g/dL12-15.5 g/dLLowS
1955-09-16Platelets [#/volume] in Blood by Automated count2210*3/uL150-400 10*3/uLLowS
1955-09-16Blasts/Leukocytes in Blood by Manual count14%None seen normallyHighS
1955-09-16Blasts/cells in Bone marrow34%Below 5% normally; 20% or more defines AMLHighS
1955-09-16INR in Platelet poor plasma by Coagulation assay1.1{INR}0.8-1.2NormalS
1955-09-16Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay310mg/dL200-400 mg/dLNormalS

Physical Exam

Vital signs recorded on 1955-09-16; see the Vital Signs section. [S]

SystemFinding
GeneralPale and tired but alert; weight 53.8 kg; pulse 100
SkinSeveral bruises on the thighs and shins; petechiae on the lower legs
MouthGum petechiae; no gum swelling
Lymph nodesNone enlarged
AbdomenNo enlarged liver or spleen
Bone marrow siteRight posterior iliac crest dressing dry

Problems

ProblemClinical statusVerificationCodeProvenance
Two months of tiredness, easy bruising and bleeding gums, with pancytopenia and 12 percent blasts on the blood smear; acute leukemia suspected and urgent hematology review bookedresolvedconfirmed D61.818S — Synthetic presenting concern at the index visit, superseded by the bone marrow diagnosis two days later; its timing echoes the documented decline in her health (D).
Acute myeloid leukemia diagnosed on bone marrow biopsy (34 percent myeloblasts), in a physicist with decades of occupational exposure to ionizing radiation; synthetic modern diagnosis linked to her documented leukemiaactiveconfirmed C92.00S — Synthetic modern diagnosis and subtype; the type of her real leukemia is not documented.
Occupational exposure to ionizing radiation over about four decades: X-ray work early in her career, laboratory work with polonium and other radioactive sources, and a laboratory accident in which a sealed polonium source ruptured on her bench about ten years agoactiveconfirmed Z57.1S — Synthetic modern coding of her documented occupational exposure.
Pulmonary tuberculosis in her forties, treated to completion; no symptoms of active diseaseactiveconfirmed Z86.11S — Synthetic modern coding of her documented tuberculosis; the treatment details are synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryBlood count with differential and smearAt diagnosis; two to three times a week during induction; before each cycleCompleted todayWhite cells 1.9, neutrophils 0.5, hemoglobin 7.1 g/dL, platelets 22 x10^3/uL, blasts 14% on the smear
LaboratoryBone marrow: morphology, flow cytometry, cytogenetics, molecular panelAt diagnosis; day 21 to 28 of cycle 1; then as response and transplant planning requireCompleted todayAspirate 34% myeloblasts with multilineage dysplasia; flow cytometry myeloid; cytogenetics and molecular panel sent
LaboratoryCoagulation tests (INR, fibrinogen) to exclude the coagulopathy of acute promyelocytic leukemiaAt diagnosisCompleted todayINR 1.1, fibrinogen 310 mg/dL: no coagulopathy; rapid PML::RARA negative
LaboratoryChemistry: electrolytes, creatinine, calcium, phosphate, uric acid, LDH, liver testsAt diagnosis; during venetoclax ramp-up for tumor lysis; then weekly in cycle 1 and before each cycleUp to dateNormal kidney and liver tests two days ago; LDH 412 U/L and uric acid 6.4 mg/dL; repeat on the first treatment day
ExaminationFitness: performance status, comorbidity (HCT-CI), echocardiogram, lung functionBefore choosing inductionOrderedECOG 1 two days ago; echocardiogram, ECG and lung function tests booked for the results review
Medication safetyTransfusion support: thresholds, irradiated and leukoreduced productsAt each blood countCompleted todayHemoglobin 7.1 g/dL with breathlessness: one unit of irradiated, leukoreduced red cells today; platelets 22 without serious bleeding: no transfusion, as the biopsy is safe at this count
Self-managementInfection prophylaxis and the fever planFrom diagnosisCompleted todayFever plan given in writing: 38.0 °C or more means the emergency department at once; thermometer at home
LaboratoryHepatitis B, hepatitis C and HIV testing before therapyOnce, before therapyCompleted todayHepatitis B surface antigen, core antibody and surface antibody, hepatitis C antibody and HIV test sent
ReferralHLA typing and allogeneic transplant evaluationAt diagnosis for any patient who may be a transplant candidateCompleted todayHLA typing sent
Self-managementOccupational exposure history and dose recordsAt diagnosisCompleted todayHistory documented; written request for records begun

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia, Version 5.2026 (2026); Döhner H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 2022 (PMID 35797463) (2022); Khoury JD, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 2022 (PMID 35732831) (2022); Arber DA, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 2022 (PMID 35767897) (2022); Carson JL, et al. Red Blood Cell Transfusion: 2023 AABB International Guidelines. JAMA 2023 (PMID 37824153) (2023); Kaufman RM, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2015 (PMID 25383671) (2015); Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update (PMID 32716741) (2020); 10 CFR 19.13, Notifications and reports to individuals (radiation exposure reports on request) (2026); 29 CFR 1910.1096, Ionizing radiation (records of exposure and disclosure to employees) (2026)

Follow-up: Review when the cytogenetics and molecular results are back, in about ten days, with the echocardiogram and lung function tests. Blood count twice weekly with transfusion as needed. Emergency department at once for a temperature of 38.0 °C or more or bleeding that does not stop. Next scheduled visit 1955-09-28: genetic results, classification and risk, fitness for treatment, early palliative care, and day 1 of azacitidine with venetoclax. [S]